产品名称 | NebuSelect™ Recombinant Human HPN, His-tag |
---|---|
目录号 | NBL-240861 |
别名 | HPN; Hpxn; FLJ56652; Hemopexin; HPX; HX; Hepsin; HPN;TMPRSS1 |
外观 | see COA |
分子量 | Arg45-Leu417 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P05981 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-240861-100ug | 100ug | Inquire | Inquire | |
NBL-240861-1mg | 1mg | Inquire | Inquire | |
NBL-240861-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human HPN, His-tag
Catalog#:
NBL-240861
Description:
NebuSelect™ Recombinant Human HPN, His-tag(Cat#NBL-240861) is expressed in HEK293 with His tag at the C-Terminus.It contains Arg45-Leu417.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 42 kDa. Due to the protein cleaved into the following two chains, so it migrates to 18-22 kDa and 30 kDa based on Bis-Tris PAGE result.
Target Name:
HPN; Hpxn; FLJ56652; Hemopexin; HPX; HX; Hepsin; HPN;TMPRSS1
Target Information:
Home parenteral nutrition (HPN) has been proposed as the treatment of choice in patients suffering from intestinal failure (IF) and has been claimed to improve survival and quality of life either in patients with benign disorders or even in those with malignancies. HPN seems to have beneficial effect but it should be considered with caution by the physicians who should take into account the indications of each patient to receive parenteral nutrition, the underlying disease and prognosis and the access of each patient to home care services.
Amino Acid Sequence:
Arg45-Leu417
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.